Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • Singapore Stocks
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Invivyd, Inc.

0.7241
-0.0039-0.54%
Volume:889.91K
Turnover:657.72K
Market Cap:86.86M
PE:-0.61
High:0.7717
Open:0.7477
Low:0.7204
Close:0.7280
Loading ...
OverviewCompanyNewsFilings

Invivyd's FDA Setback Highlight's Risks of Pipeline Concentration -- Market Talk

Dow Jones
·
24 Feb

5 Stocks That More Than Doubled Halfway Through Q1

Zacks
·
24 Feb

BUZZ-U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop

Reuters
·
24 Feb

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday

MT Newswires Live
·
24 Feb

Invivyd Is Maintained at Buy by D. Boral Capital

Dow Jones
·
24 Feb

Invivyd Shares Down as Regulators Decline Expanded Use for Covid-19 Treatment

Dow Jones
·
24 Feb

Invivyd's Request to Treat Covid-19 Patients With Pemgarda Rejected by US FDA

MT Newswires Live
·
24 Feb

BUZZ-Invivyd falls after US FDA declines to expand emergency use of COVID-19 drug

Reuters
·
24 Feb

FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing PEMGARDA EUA for Pre-Exposure Prophylaxis of COVID-19 in Certain Immunocompromised Patients

GlobeNewswire
·
24 Feb

Why Invivyd, Inc. (IVVD) Is Soaring This Year So Far

Insider Monkey
·
18 Feb

Analyst Rate

Buy
Buy
66.67%
Hold
33.33%
Sell
0.00%

Corporate Actions

Financial Report Announcement
May 15, 2025 Pre-Market
Financial Report Announcement
Mar 20, 2025 Pre-Market
Financial Report Announcement
Feb 03, 2025 Pre-Market
Financial Report Announcement
Nov 14, 2024 Pre-Market
Financial Report Announcement
Oct 29, 2024 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.61
Current
-3.85
Sector Average
77.35%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.61
Maximum
-0.21
+1 STD
4.99
Minimum
-52.24
-1 STD
-12.70
Average
-3.85

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.